Company profile: Thoratec
1.1 - Company Overview
Company description
- Provider of mechanical circulatory support medical devices for patients with advanced heart failure. A world leader with the broadest product portfolio, including HeartMate LVAS and Thoratec VAD, addressing the full range of clinical needs, with more than 20,000 devices implanted.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Thoratec
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
Huinno
HQ: South Korea
Website
- Description: Provider of AI-enabled wearable cardiac monitoring solutions: MEMO Solution and MEMO Patch 2 for 14-day continuous ECG monitoring; MEMO Care, a web platform for patient management with cloud ECG storage/analysis; MEMO Link, a gateway transmitting real-time biometric data to avoid network disruptions in emergencies; and MEMO Q for remote patient monitoring and ECG/biometric diagnostics, helping prevent arrhythmia, stroke, and hypertension.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Huinno company profile →
Esperion Therapeutics
HQ: United States
Website
- Description: Provider of pharmaceutical products for cardiovascular and metabolic diseases, including bempedoic acid to lower LDL-cholesterol in hypercholesterolemia patients inadequately treated with current lipid-modifying therapies, and a fixed-dose combination of bempedoic acid and ezetimibe to further reduce LDL-cholesterol.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Esperion Therapeutics company profile →
Intact Vascular
HQ: United States
Website
- Description: Provider of minimally invasive peripheral vascular products. Develops the Tack-It Endovascular System to optimize peripheral balloon angioplasty in peripheral artery disease. Offers imaging and navigation tools for peripheral and aortic procedures, including 3D roadmapping and real-time guidance, mechanical thrombectomy, laser sheath for embedded IVC filter removal, and digital IVUS for assessment and therapy guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intact Vascular company profile →
BTG
HQ: United Kingdom
Website
- Description: Provider of interventional medicine, pharmaceuticals, and licensing solutions, acquiring, developing, manufacturing, and commercializing products globally. Interventional oncology offerings include beads and TheraSphere Y-90 Glass Microspheres for HCC; other devices include Jetstream Atherectomy System, Vercise Genus DBS, Varithena 1% foam, WaveWriter Alpha SCS, and AcuPulse DUO CO2 Laser.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BTG company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Thoratec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Thoratec
2.2 - Growth funds investing in similar companies to Thoratec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Thoratec
4.2 - Public trading comparable groups for Thoratec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →